Clever Leaves Holdings Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Clever Leaves Holdings Inc. is a multinational cannabis company specializing in the cultivation, processing, and distribution of pharmaceutical-grade cannabinoid products primarily for medical and pharmaceutical use. The company's core product portfolio includes high-quality dried cannabis flower, cannabinoid extracts such as oils and distillates, and finished pharmaceutical formulations offered in various delivery methods including capsules and oral solutions. Clever Leaves also provides white-label product manufacturing services leveraging its GMP and EU-GMP certified facilities. The company operates large-scale cultivation sites, notably in Colombia, with capabilities compliant with Good Agricultural and Collection Practices (GACP) and Good Manufacturing Practices (GMP), supplying pharmaceutical companies and distributors in regulated markets globally, including Germany, Australia, Brazil, and the United States. Founded in 2016 and headquartered in New York City, Clever Leaves maintains a vertically integrated business model emphasizing sustainable cultivation and pharmaceutical-grade production standards. In the past two years, Clever Leaves has undergone significant strategic changes including the wind-down and sale of its Portuguese processing and cultivation operations to consolidate resources and increase cost efficiencies in its Colombian facilities, which now span over 1.8 million square feet of cultivation capacity. The company has pursued a focus on key strategic markets such as Germany and Brazil and has strengthened its global distribution network through partnerships, including a commercial partnership with pharmaceutical manufacturing company IDT Australia to supply GACP-certified cannabis flowers. Clever Leaves has also continued to advance its product innovation pipeline and regulatory certifications, maintaining pharmaceutical-grade standards with EU-GMP certification for both cannabis extracts and dry flower. Operationally, the company has implemented restructuring and cost-saving measures aimed at improving financial stability and capital efficiency while positioning itself as a leaner, more agile multinational operator in the global medicinal cannabis industry. Clever Leaves trades on the NASDAQ under the ticker symbol CLVR and continues to expand its footprint through a global supply chain and research-driven approach.
Comparing Clever Leaves (NASDAQ:CLVR) and Palatin Technologies (PINK:PTNT)
Clever Leaves Announces Voluntary Delisting and SEC Deregistration
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
High Growth: Top Pot Stocks Making Moves into March 2024
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors
Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder
Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
Clever Leaves Holdings, Inc. (CLVR) Q3 2023 Earnings Call Transcript
Clever Leaves Reports Third Quarter 2023 Results
Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET
Clever Leaves Regains Compliance with Nasdaq Minimum Bid Price Requirement
Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company
Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements
Clever Leaves Holdings, Inc. (CLVR) Q2 2023 Earnings Call Transcript
Clever Leaves Reports Second Quarter 2023 Results
3 Top Marijuana Stocks To Watch Before The Weekend
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET